Matthew Wyatt provides 18 years of executive management and entrepreneurial experience in the medical device industry, and has been the catalyst for creating high-growth US based companies entering the domestic and international healthcare marketplace. Mr. Wyatt’s operational experience includes leading technical, highly educated personnel, capital raises, design for manufacturing, regulatory, business development, identifying emerging and disruptive technologies, deal structure and building strategic partnerships with key industry thought leaders, innovators and investors.
He was involved in the creation of the newly formed spine organization for Synthes USA (NYSE:JNJ) in 1995 and served in sales, management and technical roles. He later became involved in the early stages of SpineCore, Inc during the FDA/IDE trial with prosthetic discs. After SpineCore was acquired by Stryker (NYSE:SYK), Mr. Wyatt became involved in the capital raise and co-development of K2M, Inc in 2005. He was K2M’s largest geographic and dollar volume distributor of spinal implants grossing over $80M in sales under his leadership. After Welsh-Carson acquired K2M common stock holders in July, 2010, Mr. Wyatt negotiated the acquisition of his organization by K2M (NASDAQ:KTWO) in December, 2010. He is also the cofounder of Tutela Medicus (sold to Paragon Medical in 2007) Nexxt Spine, LLC, (sold in 2013) a manufacturer and IP holder of internal fixation devices, and AMB Surgical, LLC, intellectual property specific to the automated grow rod systems and software for pediatric deformities and abnormalities (sold in 2014).
In April, 2013, Mr. Wyatt founded Recovery Force and serves as the company’s President/CEO. The company designs and develops “active” compression technology developed for and will be marketed to the athletic performance, medical and military marketplaces beginning in 2017.